Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Intravitreal dexamethasone implant as an alternative to systemic steroids as prophylaxis for uveitic cataract surgery: a randomized trial.

Sudhalkar A, Vasavada A, Bhojwani D, Vasavada V, Vasavada S, Vasavada V, Srivastava S.

Eye (Lond). 2019 Jul 18. doi: 10.1038/s41433-019-0534-8. [Epub ahead of print]

PMID:
31320735
2.

Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.

Campa C, Salsini G, Perri P.

Curr Eye Res. 2018 Mar;43(3):362-367. doi: 10.1080/02713683.2017.1396615. Epub 2017 Nov 9.

PMID:
29120255
3.

Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.

Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S.

Cochrane Database Syst Rev. 2018 Apr 18;4:CD011599. doi: 10.1002/14651858.CD011599.pub2. Review.

4.

Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.

Lim BX, Lim CH, Lim DK, Evans JR, Bunce C, Wormald R.

Cochrane Database Syst Rev. 2016 Nov 1;11:CD006683. Review.

5.

Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.

Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group.

Ophthalmology. 2019 Feb;126(2):283-295. doi: 10.1016/j.ophtha.2018.08.021. Epub 2018 Sep 27.

PMID:
30269924
6.

Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-centre, prospective, randomized trial.

Mora P, Gonzales S, Ghirardini S, Rubino P, Orsoni JG, Gandolfi SA, Majo F, Guex-Crosier Y.

Acta Ophthalmol. 2016 Sep;94(6):e390-4. doi: 10.1111/aos.12955. Epub 2016 Feb 5.

7.

Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis.

Jinagal J, Gupta G, Agarwal A, Aggarwal K, Akella M, Gupta V, Suri D, Gupta A, Singh S, Ram J.

Indian J Ophthalmol. 2019 Jan;67(1):69-74. doi: 10.4103/ijo.IJO_713_18.

8.

Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification.

Gupta A, Ram J, Gupta A, Gupta V.

Ocul Immunol Inflamm. 2013 Dec;21(6):462-7. doi: 10.3109/09273948.2013.822087. Epub 2013 Aug 13.

PMID:
23941542
9.

Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.

Sze AM, Luk FO, Yip TP, Lee GK, Chan CK.

Eur J Ophthalmol. 2015 Mar-Apr;25(2):168-72. doi: 10.5301/ejo.5000523. Epub 2014 Oct 21.

PMID:
25363857
10.

PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.

Khurana RN, Bansal AS, Chang LK, Palmer JD, Wu C, Wieland MR.

Retina. 2017 Sep;37(9):1692-1699. doi: 10.1097/IAE.0000000000001406.

PMID:
27893624
11.
12.

Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.

Larochelle MB, Smith J, Dacey MS.

Am J Ophthalmol. 2016 Jun;166:149-153. doi: 10.1016/j.ajo.2016.03.049. Epub 2016 Apr 8.

PMID:
27066725
13.

Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety.

Mishra SK, Gupta A, Patyal S, Kumar S, Raji K, Singh A, Sharma V.

Int J Retina Vitreous. 2018 Mar 26;4:13. doi: 10.1186/s40942-018-0114-2. eCollection 2018.

14.

Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.

Maca SM, Abela-Formanek C, Kiss CG, Sacu SG, Benesch T, Barisani-Asenbauer T.

Clin Exp Ophthalmol. 2009 May;37(4):389-96. doi: 10.1111/j.1442-9071.2009.02033.x.

PMID:
19594566
15.

Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.

Mylonas G, Georgopoulos M, Malamos P, Georgalas I, Koutsandrea C, Brouzas D, Sacu S, Perisanidis C, Schmidt-Erfurth U; Macula Study Group Vienna.

Curr Eye Res. 2017 Apr;42(4):648-652. doi: 10.1080/02713683.2016.1214968. Epub 2016 Sep 9.

PMID:
27612922
16.

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone.

Zola M, Briamonte C, Lorenzi U, Machetta F, Grignolo FM, Fea AM.

Clin Ophthalmol. 2017 Nov 6;11:1949-1956. doi: 10.2147/OPTH.S141153. eCollection 2017.

17.

Phacoemulsification versus small incision cataract surgery in patients with uveitis.

Bhargava R, Kumar P, Sharma SK, Kumar M, Kaur A.

Int J Ophthalmol. 2015 Oct 18;8(5):965-70. doi: 10.3980/j.issn.2222-3959.2015.05.20. eCollection 2015.

18.

INTRAVITREAL DICLOFENAC VERSUS INTRAVITREAL TRIAMCINOLONE FOR THE TREATMENT OF UVEITIC CYSTOID MACULAR EDEMA.

Soheilian M, Eskandari A, Ramezani A, Rabbanikhah Z, Esmaeilpour NF, Soheilian R.

Retina. 2013 Apr 11. [Epub ahead of print]

PMID:
23584700
19.

A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.

Soheilian M, Eskandari A, Ramezani A, Rabbanikhah Z, Soheilian R.

Ocul Immunol Inflamm. 2013 Apr;21(2):124-9. doi: 10.3109/09273948.2012.745883.

PMID:
23697857
20.

Supplemental Content

Support Center